Industry News
Genes In Healthy Breast Tissue May Predict Who Will Benefit From Drugs To Prevent Estrogen-Sensitive Breast Cancer
Mar 21, 2013
A newly identified set of genes may predict which women are at high risk for getting breast cancer that is sensitive to estrogen and, therefore, would be helped by taking drugs to prevent it, reports a new Northwestern Medicine study... Read More
Tiny, Portable Personal Blood Testing Implant That Sends Data Through Mobile Phone Network
Mar 21, 2013
Humans are veritable chemical factories - we manufacture thousands of substances and transport them, via our blood, throughout our bodies. Some of these substances can be used as indicators of our health status. A team of EPFL scientists has developed a tiny device that can analyze the concentration of these substances in the blood... Read More
"Tiny Lab" Implanted Under Skin Transmits Blood Marker Levels
Mar 20, 2013
Scientists in Switzerland have developed a "tiny lab" on a chip that when implanted just under the skin can track levels of up to five substances in the blood and transmit the results wirelessly to a smartphone or other receiving device in a "telemedicine" network... Read More
Difference In Radical Prostatectomy Outcomes Between Surgeons Confirmed By Study
Mar 20, 2013
New evidence from Sweden confirms previous studies which suggest that functional outcomes after radical prostatectomy may vary between surgeons, especially in relation to continence. However, the group found no evidence of heterogeneity in potency-related outcomes... Read More
Myeloma UK Funded Research Leads To Breakthrough In Understanding Causes Of Myeloma Cancer
Mar 20, 2013
The Myeloma UK funded Research Programme at The Institute of Cancer Research (ICR) has made another important discovery about the genetics of myeloma. Researchers at the ICR have identified an inherited gene that increases the risk of developing myeloma by making the DNA more susceptible to damage. This may also have implications for other forms of cancer... Read More
Two In Three Cancer Patients Who Died In Hospital Wanted To Die At Home
Mar 20, 2013
Macmillan Cancer Support reveals that two in three (65%) cancer patients in England who died in hospital, wanted to die at home1. This comes as a cross-party committee of MPs and Lords today strongly recommend that the Government introduce free social care for people at the end of life "at the earliest opportunity" to enable more people to die in the place of their choice2... Read More
In Prostate Screening, Digital Rectal Exam Still Important
Mar 20, 2013
The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers. The digital rectal examination is a procedure where a physician feels the surface of the prostate with a gloved finger... Read More
For Bladder Cancer Patients Researchers Propose A Novel Prognostic Model For Disease-Specific Survival
Mar 20, 2013
A new study from Japan investigated various prognostic indicators, including clinico-pathological and pre-operative hematological factors to develop a novel prognostic factors-based risk stratification model for disease-specific survival (DSS) in bladder cancer (BCa) patients treated with radical cystectomy (RC)... Read More
In Patients With Metastatic Renal Cell Carcinoma Scientists Investigate Potential Markers For A Response To Sunitinib
Mar 20, 2013
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study presented at the 28th Annual EAU Congress currently on-going in Milan... Read More
Bone Marrow-Derived Mesenchymal Stem Cells From Third Party Donors Found Effective, Safe In Treating Poor Graft Function
Mar 20, 2013
When a research team in China evaluated the efficacy and safety of using mesenchymal stem cells (MSCs) expanded from the bone marrow of non-self-donors to treat patients experiencing poor graft function (PGF) after receiving transplants of non-self-donated blood stem cells (allo-HSCT), they found that the mesenchymal stem cells were both safe and effective for treating primary and secondary PGF... Read More
Previous Page Next Page